NIH, 11 biopharmaceutical companies partner to speed development of cancer immunotherapy strategies
The National Institutes of Health and 11 leading biopharmaceutical companies Thursday launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaborati..





